European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
Authors:
Open Access
- 27 July 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (8) , 1063-1069
Abstract
The correct rate of implantation for implantable cardioverter defibrillator (ICD) and CRT-D devices is not known, but practice surveys suggest persistent under-utilization of these treatments on both sides of the Atlantic. Although recent clinical trial results and the implementation of current guidelines appear to have encouraged a growth of the rate of implantation in most countries, there remains a remarkable trans- Atlantic difference which has not changed much for more than 10 years. For every European ICD implant, there are four implants in the USA after adjustment for the size of the populations. Since very large variations in the implantation rates also occur between and within European Countries, an opportunity is afforded to explore the possible cause of these differences. It seems very unlikely to be explained simply by guideline discrepancies, financial constraints, or differences in disease prevalence. Instead, it is more likely to be attributable to a relative paucity of electrophysiologists, and their associated resources. In turn, the failure to establish effective educational programmes, screening, and referral pathways contributes to far fewer patients. It seems unlikely that adequate equity of access to this potentially lifesaving treatment will be provided until adequate registries, audits, and gap analyses are undertaken throughout Europe.Keywords
This publication has 15 references indexed in Scilit:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesCirculation, 2008
- Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart FailureJAMA, 2007
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm AssociationEP Europace, 2007
- Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation?Netherlands Heart Journal, 2007
- ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyEuropean Heart Journal, 2006
- The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single districtEP Europace, 2005
- Task Force on Sudden Cardiac Death of the European Society of CardiologyEuropean Heart Journal, 2001
- The Utilization of the Implantable Defibrillator—a European EnigmaEuropean Heart Journal, 2000
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980